See more : Centrum Medyczne ENEL-MED S.A. (ENE.WA) Income Statement Analysis – Financial Results
Complete financial analysis of Evolva Holding SA (0QQJ.L) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Evolva Holding SA, a leading company in the Industrial Materials industry within the Basic Materials sector.
- Manomay Tex India Limited (MANOMAY.BO) Income Statement Analysis – Financial Results
- Labo Print S.A. (LAB.WA) Income Statement Analysis – Financial Results
- Dolphin Offshore Enterprises (India) Limited (DOLPHIN.NS) Income Statement Analysis – Financial Results
- Sweco AB (publ) (SWEC-A.ST) Income Statement Analysis – Financial Results
- Korshynov Mining Plant Public Joint Stock Company (KOGK.ME) Income Statement Analysis – Financial Results
Evolva Holding SA (0QQJ.L)
About Evolva Holding SA
Evolva Holding SA discovers, researches, develops, and commercializes nature-based ingredients for use in flavor and fragrances, health ingredients, health protection, and other sectors in Switzerland, the United States, and internationally. It offers various ingredients comprising Veri-te Resveratrol, a nature-made polyphenol that occurs naturally in grapes and other plants, including peanuts, cranberries, and berries; L-Arabinose, a flavoring agent used in Maillard reaction; Valencene, an aroma component of citrus fruit and citrus-derived odorants; Nootkatone, an aroma ingredient of grapefruit obtained via biochemical oxidation of valencene; and Vanillin, a primary component of vanilla bean extract. The company was founded in 2004 and is headquartered in Reinach, Switzerland.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.16M | 15.54M | 9.88M | 7.54M | 11.60M | 8.93M | 6.85M | 8.75M | 9.40M | 10.74M | 8.71M | 7.01M |
| Cost of Revenue | 0.00 | 24.43M | 25.45M | 17.45M | 14.06M | 14.22M | 12.92M | 10.11M | 8.54M | 24.15M | 18.88M | 19.46M |
| Gross Profit | 4.16M | -8.89M | -15.57M | -9.91M | -2.46M | -5.29M | -6.08M | -1.36M | 856.40K | -13.41M | -10.17M | -12.44M |
| Gross Profit Ratio | 100.00% | -57.22% | -157.66% | -131.47% | -21.22% | -59.23% | -88.74% | -15.59% | 9.11% | -124.77% | -116.81% | -177.41% |
| Research & Development | 0.00 | 3.99M | 6.27M | 6.06M | 6.15M | 11.34M | 20.36M | 26.08M | 28.29M | 23.03M | 18.88M | 19.46M |
| General & Administrative | 3.65M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 6.96M | 6.87M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 558.10K | 654.70K |
| SG&A | 3.65M | 10.48M | 10.06M | 5.33M | 11.52M | 13.99M | 17.44M | 14.55M | 12.25M | 9.35M | 7.52M | 7.52M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.96M | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 3.65M | 14.47M | 16.33M | 11.39M | 17.67M | 25.33M | 37.80M | 40.63M | 36.58M | 9.69M | 7.35M | 4.97M |
| Cost & Expenses | 3.65M | 38.90M | 41.78M | 28.85M | 31.72M | 39.55M | 50.73M | 50.74M | 45.13M | 33.84M | 26.23M | 24.43M |
| Interest Income | 1.22M | 76.80K | 50.70K | 57.20K | 300.00 | 360.20K | 380.90K | 304.90K | 380.60K | 357.10K | 513.80K | 659.30K |
| Interest Expense | 0.00 | 760.70K | 983.00K | 1.11M | 583.30K | 361.90K | 407.80K | 346.30K | 435.60K | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 5.21M | 8.09M | 8.60M | 8.17M | 7.85M | 7.49M | 8.22M | 7.20M | 6.94M | 3.75M | 3.38M | 3.29M |
| EBITDA | 5.71M | -34.52M | -31.83M | -20.60M | -13.18M | -23.47M | -36.86M | -33.97M | -28.79M | -19.00M | -14.31M | -16.68M |
| EBITDA Ratio | 137.40% | -98.26% | -235.90% | -174.20% | -105.90% | -258.97% | -520.77% | -397.73% | -306.30% | -176.88% | -164.38% | -237.85% |
| Operating Income | 506.20K | -23.36M | -31.90M | -21.30M | -20.13M | -30.62M | -43.88M | -42.00M | -35.73M | -22.76M | -17.69M | -19.97M |
| Operating Income Ratio | 12.18% | -150.32% | -322.96% | -282.53% | -173.57% | -342.78% | -640.89% | -480.08% | -380.08% | -211.80% | -203.16% | -284.68% |
| Total Other Income/Expenses | -101.72M | -20.01M | 622.00K | -8.58M | -1.49M | -699.20K | -1.62M | 497.20K | -129.00K | -299.80K | -348.40K | 1.90M |
| Income Before Tax | -101.22M | -43.37M | -41.41M | -29.88M | -21.61M | -31.32M | -45.50M | -40.67M | -35.86M | -23.46M | -18.04M | -18.07M |
| Income Before Tax Ratio | -2,434.99% | -279.07% | -419.21% | -396.28% | -186.39% | -350.60% | -664.49% | -464.93% | -381.46% | -218.31% | -207.16% | -257.62% |
| Income Tax Expense | 0.00 | 0.00 | -141.10K | -12.00K | 25.30K | -2.10M | -7.02M | -5.16M | -4.07M | 1.61M | 1.86M | 1.50M |
| Net Income | -101.22M | -43.37M | -41.27M | -29.87M | -21.64M | -29.21M | -38.98M | -35.97M | -31.89M | -21.35M | -15.73M | -16.01M |
| Net Income Ratio | -2,434.99% | -279.07% | -417.78% | -396.12% | -186.61% | -327.05% | -569.28% | -411.20% | -339.29% | -198.74% | -180.70% | -228.17% |
| EPS | -14.04 | -10.13 | -11.72 | -9.49 | -7.02 | -9.48 | -20.21 | -18.92 | -18.93 | -19.41 | -17.29 | -23.09 |
| EPS Diluted | -14.04 | -10.13 | -11.72 | -9.49 | -7.02 | -9.48 | -20.21 | -18.92 | -18.93 | -19.41 | -17.29 | -23.09 |
| Weighted Avg Shares Out | 7.21M | 4.28M | 3.52M | 3.15M | 3.08M | 3.08M | 1.93M | 1.90M | 1.69M | 1.10M | 910.03K | 693.29K |
| Weighted Avg Shares Out (Dil) | 7.21M | 4.28M | 3.52M | 3.15M | 3.08M | 3.08M | 1.93M | 1.90M | 1.69M | 1.10M | 910.03K | 693.29K |
Source: https://incomestatements.info
Category: Stock Reports